Issue 6

The Future of Glaucoma: Perspectives for Optometry
John Flanagan, OD, PhD, DSc (hon), FCOptom, FAAO

Evaluating Glaucoma Progression
Murray Fingeret, OD

Learning Objectives:

Upon completion of this activity, participants will be able to:

• Describe the pathophysiology of glaucoma and new imaging techniques and biomarkers of disease.

• Describe the latest advances in pharmacological and surgical treatments to manage glaucoma and the future goals of treatment.

• Monitor glaucoma patients and glaucoma suspects more effectively.

• Analyze OCT and VFT results more accurately.

Issue 5

Primary Angle Closure Glaucoma: An Update for Optometrists
Ambika Hoguet, MD

Secondary Open-angle Glaucoma Detection and Management
Daniel K. Roberts, OD, PhD

Learning Objectives:

Upon completion of this activity, participants will be able to:

• Diagnose and classify angle closure, angle closure suspect, and PACG.

• Provide better care to patients at risk for angle closure.

• Review key clinical features of common types of secondary open-angle glaucoma.

• Improve detection of secondary open-angle glaucoma based on history and clinical examination.

Issue 4

New Trends in Medical Treatment of Glaucoma
Paul Karpecki, OD, FAAO

Caring for Patients Who Undergo Glaucoma Surgery 
Scott G. Hauswirth, OD, FAAO

Learning Objectives:

Upon completion of this activity, participants will be able to:

• Analyze the need for new drugs and technologies for medical management of glaucoma.

• Examine the mechanisms of action of IOP-lowering agents used to treat glaucoma in order to provide the most appropriate therapy. 

• Assess professional readiness to participate in perisurgical glaucoma care.

• Offer pre-referral counsel to glaucoma patients.

Issue 3

Normal Tension Glaucoma
Murray Fingeret, OD, FAAO

Visual Field Testing for Glaucoma
Leo Semes, OD, FAAO

Learning Objectives:

Upon completion of this activity, participants will be able to:

• Differentiate normal tension from high tension glaucoma.

• Conduct an appropriate workup to diagnose normal tension glaucoma.

• Identify early glaucomatous damage on visual field based on established guideline for minimal glaucomatous defect.

• Properly stage glaucoma using the AGS severity scale.

Issue 2

Current Medical Treatment of Glaucoma
Bruce E. Onofrey, RPH, OD, FAAO

Improving Adherence to Glaucoma Medications
Baharak Asefzadeh, OD, MS, FAAO

Learning Objectives:

Upon completion of this activity, participants will be able to:

• Select appropriate medical therapy for the individual patient by evaluating both the efficacy and safety of glaucoma drugs.

• Identify ocular perfusion pressure as a risk factor for glaucoma progression.

• Identify barriers to medication adherence among their patients.

• Take steps to reduce nonadherence among glaucoma patients in their practices.

Issue 1

Who Has Glaucoma? Definitions and Diagnosis
Steven L. Mansberger, MD, MPH

Aqueous Humor Dynamics: What IOP Means for the Clinician
John J. McSoley, OD

Learning Objectives:

Upon completion of this activity, participants will be able to:

• Define glaucoma and common subtypes.

• Discuss the role of IOP in glaucoma diagnosis.

• Delineate the relationship between aqueous humor dynamics, IOP, and glaucoma.

• Identify individual IOP reduction needs in glaucoma patients.